Sera Prognostics Files 8-K Report

Ticker: SERA · Form: 8-K · Filed: Jan 13, 2025 · CIK: 1534969

Sentiment: neutral

Topics: sec-filing, 8-k, disclosure

TL;DR

Sera Prognostics filed an 8-K, likely containing important company updates for investors.

AI Summary

On January 13, 2025, Sera Prognostics, Inc. filed an 8-K report. The filing primarily concerns Regulation FD Disclosure and the inclusion of Financial Statements and Exhibits. No specific financial figures or material events were detailed in the provided excerpt, but the filing indicates standard corporate reporting.

Why It Matters

This 8-K filing indicates Sera Prognostics, Inc. is providing updates or disclosures to the SEC, which could contain material information for investors.

Risk Assessment

Risk Level: low — The provided text is a standard SEC filing cover page and does not contain specific negative or positive news, making the immediate risk level low.

Key Players & Entities

FAQ

What is the primary purpose of this 8-K filing by Sera Prognostics, Inc.?

The primary purpose of this 8-K filing is for Regulation FD Disclosure and to report Financial Statements and Exhibits.

What is the date of the earliest event reported in this filing?

The date of the earliest event reported in this filing is January 13, 2025.

What is Sera Prognostics, Inc.'s Commission File Number?

Sera Prognostics, Inc.'s Commission File Number is 001-40606.

Where are Sera Prognostics, Inc.'s principal executive offices located?

Sera Prognostics, Inc.'s principal executive offices are located at 2749 East Parleys Way, Suite 200, Salt Lake City, Utah, 84109.

What is the telephone number for Sera Prognostics, Inc.?

The telephone number for Sera Prognostics, Inc. is (801) 990-0520.

Filing Stats: 538 words · 2 min read · ~2 pages · Grade level 10.8 · Accepted 2025-01-13 17:26:31

Key Financial Figures

Filing Documents

01 Regulation FD Disclosure

Item 7.01 Regulation FD Disclosure. On January 13, 2025, Sera Prognostics, Inc. (the "Company") will post a new investor presentation to its corporate website. Slides from this presentation are also scheduled to be shared at the 43rd Annual J.P. Morgan Healthcare Conference on January 16, 2025 at 9:45 a.m. PT. A copy of the investor presentation is filed as Exhibit 99.1 hereto and incorporated by reference herein. The information contained in Item 7.01, including Exhibit 99.1 furnished herewith, shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities under that section, nor shall it be deemed incorporated by reference into any registration statement or other document pursuant to the Securities Act of 1933, as amended, or into any filing or other document pursuant to the Exchange Act, except to the extent required by applicable law or regulation.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits Exhibit Number Description 99.1 Investor presentation to be posted on January 13, 2025. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document).

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. SERA PROGNOSTICS, INC. Date: January 13, 2025 By: /s/ Austin Aerts Austin Aerts Chief Financial Officer

View Full Filing

View this 8-K filing on SEC EDGAR

View on Read The Filing